899 filings
Page 29 of 45
8-K
rdqoguna
13 Jan 12
Other Events
12:00am
8-K
o514zf7seuv8m6hr
13 Jan 12
Other Events
12:00am
424B5
c0mkdz5
29 Dec 11
Prospectus supplement for primary offering
12:00am
8-K
rytge
29 Dec 11
Entry into a Material Definitive Agreement
12:00am
8-K
g5dp2tdqb3s9p1cn2f9y
8 Dec 11
Departure of Directors or Certain Officers
12:00am
8-K
6s64uiqzzrn6kr1kuv8x
18 Nov 11
Regulation FD Disclosure
12:00am
8-K
buyc8zk24w2popf3 489
10 Nov 11
Regulation FD Disclosure
12:00am
8-K
4pr gfkn1
8 Nov 11
Delcath Announces Fiscal 2011 Third Quarter Results
12:00am
8-K
r4z0z0 5p15jp
28 Oct 11
Fda Schedules Delcath Pre-new Drug Application Meeting Date
12:00am
8-K/A
c6brigf
13 Oct 11
Submission of Matters to a Vote of Security Holders
12:00am
8-K
p1mbq 7ls7
4 Oct 11
Departure of Directors or Certain Officers
12:00am
8-K
b7a exjmo1p0
28 Sep 11
March 2011 Data Confirm Strong Treatment Effect of Chemosaturation
12:00am
8-K
5jxop4
26 Sep 11
Graham G. Miao Appointed Chief Financial Officer; David McDonald Appointed
12:00am
8-K
clu63rby3mm13lsn9q
15 Sep 11
Positive Phase 2 Trial Results from Neuroendocrine Tumor
12:00am
8-K
xq6gwis0jrid
6 Sep 11
Delcath Announces Top-line Results from Metastatic Colorectal Cohort In Phase Ii Trial of Chemosaturation System
12:00am
8-K
ojn5 r0yekutejt
25 Aug 11
Delcath Announces Encouraging Top-line Results from Hepatobiliary Cohort In Phase Ii Trial of Chemosaturation System
12:00am
8-K
bflh9q cs
11 Aug 11
Departure of Directors or Certain Officers
12:00am
8-K
bqvzg1ms39qa 3a49f1
10 Aug 11
Delcath Systems, Inc. Second Quarter 2011
12:00am